Project Grant F31HL176167

Award Date 1/15/25
Completion Date 8/31/27
Dollars Obligated $80K
Federal Grant Program
93.837
Assistance Type
Project Grant
Place of Performance
Chapel Hill, NC 27599, USA
Similar Awards
This federal Project Grant award from the National Institute of Environmental Health Sciences (NIEHS), under the Environmental Health (CFDA 93.113) program, provides $671,165 to the University of North Carolina at Chapel Hill to support research on the genetic mechanisms underlying maladaptive respiratory responses to air pollution exposure, particularly ozone. The key objectives are to: 1) identify genes and pathways in alveolar macrophages that influence adaptation to ozone exposure, 2) map...
This Project Grant award from the National Institute of Environmental Health Sciences (NIEHS) under the Environmental Health program (CFDA 93.113) provides $242,310 to Emory University to conduct research on pollen exposure, air pollution, and respiratory health. The key objectives are to: 1) study the relationship between pollen, air pollution, and respiratory morbidity across 23 U.S. locations, including assessing social vulnerability indicators; 2) investigate potential synergistic effects of...
This Project Grant award from the National Institute of Environmental Health Sciences (NIEHS) under the Environmental Health (CFDA 93.113) program provides $419,011 to Emory University to develop innovative dimensionality reduction techniques for assessing the joint health effects of air pollution mixtures. The research aims to advance causal modeling approaches that preserve the relationships between air pollutants and health outcomes, in order to provide more accurate assessments of the public...
This Project Grant award, provided by the National Institute of Environmental Health Sciences (NIEHS) under the Environmental Health (CFDA 93.113) program, aims to investigate the link between air pollution exposure, environmental injustice, and the development of progressive pulmonary fibrosis (PPF) in patients with interstitial lung disease (ILD). The $241,811 award to the Cleveland Clinic Lerner College of Medicine will support a 5-year research project that combines patient-centered...
This Project Grant award from the National Institutes of Health (NIH) Office of the Director under the Trans-NIH Research Support program (CFDA 93.310) provides $144,086 to Lehigh University to establish the Pennsylvania Asthma-COPD Syndromic Surveillance (PASS) system. The goals of this 4-year project are to develop an early-warning system for chronic respiratory conditions like asthma and COPD that are exacerbated by air pollution and weather patterns in Pennsylvania. The project aims to...
This $274,392 Project Grant awarded by the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) supports a study to better understand the relationship between social determinants of health (SDOH) and asthma outcomes among Black and Latinx adults with moderate-to-severe asthma. The study aims to: Determine if Black and Latinx adults have unique SDOH exposomes (a set of SDOH exposures) that associate with worse asthma morbidity. It will...
This R21 Project Grant award from the National Institute of Environmental Health Sciences (NIEHS) under the Environmental Health (CFDA 93.113) program provides $433,950 to the University of California, Davis to study the impact of wildfire smoke exposure on lung injury and disease in pediatric populations. The key objectives are to: 1) Define the contribution of age on the toxicity of wood smoke particles in respiratory and alveolar epithelium, 2) Investigate the effect of early life wood...
This Project Grant award from the National Institute of Environmental Health Sciences (NIEHS) under the Environmental Health (CFDA 93.113) Federal Grant Program provides $676,077 to Colorado State University (CSU) to study the impacts of fine particulate matter (PM2.5) air pollution on cardiovascular and respiratory health outcomes. The key products and services being delivered under this award include: Deploying a national network to measure the oxidative potential of PM2.5 samples, which...
This $213,284 federal Project Grant award from the National Institute of Environmental Health Sciences (NIEHS) under the Environmental Health (CFDA 93.113) program will support research to investigate the role of extracellular vesicles (EVs) in mediating the health effects of wildfire smoke exposure, particularly in individuals with asthma. The key objectives are to examine whether EV release and content associated with the hypoxia-inducible factor 1 (HIF-1) pathway differentiate the...
This $704,105 Project Grant award from the National Institute of Environmental Health Sciences (CFDA 93.113 Environmental Health) supports research to examine the impact of multiple long-term environmental exposures on the incidence of asthma across the lifespan. The research will leverage data from large prospective cohort studies including the Nurses' Health Studies and Health Professionals Follow-up Study to assess associations between chemical, physical, and built environment exposures and...

UNDERSTANDING THE GENETIC CONTRIBUTIONS TO VARIATION IN OZONE EXPOSURE RESPONSE - PROJECT SUMMARY OZONE IS A COMMON AMBIENT AIR POLLUTANT THAT PRESENTS A SIGNIFICANT PUBLIC HEALTH HAZARD AS A TRIGGER FOR LUNG FUNCTION DECREMENTS, AIRWAY INFLAMMATION, AND EXACERBATIONS OF ASTHMA AND COPD SYMPTOMS. CONTROLLED HUMAN EXPOSURE STUDIES HAVE FOUND THAT THE SEVERITY OF THESE RESPONSES VARIES WIDELY ACROSS INDIVIDUALS WHILE THE SEVERITY OF A GIVEN INDIVIDUAL'S REACTION IS REPRODUCIBLE ACROSS MULTIPLE INDEPENDENT EXPOSURES, INDICATING A POTENTIAL GENETIC CONTRIBUTION TO ONE'S RISK FOR A SEVERE RESPONSE. RESULTS FROM ANIMAL MODELS ALSO INDICATE THAT RESPONSE TO OZONE IS A COMPLEX TRAIT. THE GENETIC VARIANTS THAT UNDERLY THIS VARIATION ARE CURRENTLY UNKNOWN AND THIS DATA GAP NEEDS TO BE ADDRESSED TO IDENTIFY HIGH-RISK INDIVIDUALS. MAPPING EXPRESSION QUANTITATIVE TRAIT LOCI (EQTL), WHICH ARE STATISTICAL ASSOCIATIONS BETWEEN VARIANTS AND GENE EXPRESSION, IS ONE APPROACH USED BY HUMAN GENETICISTS TO STUDY THE GENETIC BASIS OF COMPLEX TRAITS. HOWEVER, MOST EQTL MAPPING STUDIES HAVE USED UNPERTURBED/UNEXPOSED SAMPLES WHICH MAY MISS EQTL THAT ONLY MANIFEST AFTER EXPOSURE OR HAVE AN ALTERED MAGNITUDE OF EFFECT WITH EXPOSURE, TERMED "RESPONSE EQTL." THESE RESPONSE EQTL ARE THUS GENE-BY- ENVIRONMENT INTERACTIONS. STUDYING THESE INTERACTIONS IN HUMANS IS OFTEN DIFFICULT, MAKING IN VITRO MODELS AN ATTRACTIVE APPROACH. PRIMARY HUMAN BRONCHIAL EPITHELIAL CELLS (HBECS) ISOLATED FROM THE AIRWAY ARE A HIGHLY RELEVANT IN VITRO MODEL. HBECS CAN BE READILY CULTURED INTO A WELL-DIFFERENTIATED PSEUDO-STRATIFIED EPITHELIUM SIMILAR TO THAT FOUND IN VIVO AND ARE CULTURED AT AN AIR-LIQUID INTERFACE, ENABLING IN VITRO EXPOSURES WHICH MIMIC IN VIVO EXPOSURES. ADDITIONALLY, USING PRIMARY CELLS FROM DIFFERENT DONORS PROVIDES THE GENETIC VARIATION NECESSARY FOR MAPPING EQTL. THE GOAL OF MY PROJECT IS TO USE THIS IN VITRO MODEL TO IDENTIFY OZONE RESPONSE EQTL, GENOME- WIDE, AND IDENTIFY OVERLAPPING SIGNALS WITH ASTHMA AND COPD GWAS LOCI. I HYPOTHESIZE THAT MAPPING OZONE RESPONSE EQTL IN A PHYSIOLOGICALLY RELEVANT CELL CULTURE MODEL WILL IDENTIFY VARIANTS ASSOCIATED WITH RESPONSE VARIABILITY. FURTHER, I HYPOTHESIZE THAT SOME OF THESE RESPONSE EQTL WILL COLOCALIZE WITH GWAS SIGNALS FOR ASTHMA AND COPD, WHICH HAVE BOTH BEEN SHOWN TO BE AFFECTED BY AIR POLLUTION EXPOSURE. IN AIM 1, I WILL CHARACTERIZE THE TRANSCRIPTOMIC RESPONSE TO OZONE IN HBECS FROM 202 DONORS WITH DIVERSITY IN AGE, SEX, GENETIC ANCESTRY, AND SMOKING HISTORY. IN AIM 2, I WILL MAP BASELINE AND OZONE RESPONSE EQTL, USING THE DIFFERENCE IN GENE EXPRESSION BETWEEN FILTERED AIR AND OZONE EXPOSED CULTURE PAIRS FROM EACH DONOR TO MAP RESPONSE EQTL. IN AIM 3 I WILL PERFORM COLOCALIZATION BETWEEN OZONE RESPONSE EQTL AND GWAS FOR ASTHMA AND COPD, FOLLOWED BY MENDELIAN RANDOMIZATION ANALYSIS TO EVALUATE A SIGNAL'S EFFECT ON DISEASE VIA GENE EXPRESSION. IN TOTAL, I WILL IDENTIFY GENETIC DRIVERS OF INCREASED RISK FOR SEVERE RESPONSE TO OZONE USING A RESPONSE EQTL STRATEGY TO FIND CONTEXT-DEPENDENT EQTL, WHICH WILL IMPROVE IDENTIFICATION OF SUSCEPTIBLE INDIVIDUALS AND INFORM POLICY REGARDING SAFE LEVELS OF EXPOSURE.

Posted 7/15/24, 12:00 AM